Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Inflammatory bowel disease and pregnancy].
Garrido E, Van Domselaar M, Morales S, López-Sanromán A. Garrido E, et al. Gastroenterol Hepatol. 2010 Aug-Sep;33(7):517-29. doi: 10.1016/j.gastrohep.2009.11.006. Epub 2010 Feb 2. Gastroenterol Hepatol. 2010. PMID: 20129703 Spanish.
Hepatitis E seroprevalence in inflammatory bowel disease.
Senosiain C, González-Tallón A A, López-Sanromán A, Mateos ML, Pérez-Gracia MT, García-Sánchez MC, Maroto M, Garrido E. Senosiain C, et al. Among authors: garrido e. Gastroenterol Hepatol. 2016 Mar;39(3):185-90. doi: 10.1016/j.gastrohep.2015.06.004. Gastroenterol Hepatol. 2016. PMID: 26257097
Mercaptopurine and inflammatory bowel disease: the other thiopurine.
Bermejo San José F, Algaba A, López Durán S, Guerra I, Aicart M, Hernández-Tejero M, Garrido E, de Lucas M, Bonillo D, López Sanromán A. Bermejo San José F, et al. Among authors: garrido e. Rev Esp Enferm Dig. 2017 Jan;109(1):10-16. doi: 10.17235/reed.2016.4546/2016. Rev Esp Enferm Dig. 2017. PMID: 27809554 Free article.
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
Casanova MJ, Chaparro M, García-Sánchez V, Nantes O, Leo E, Rojas-Feria M, Jauregui-Amezaga A, García-López S, Huguet JM, Arguelles-Arias F, Aicart M, Marín-Jiménez I, Gómez-García M, Muñoz F, Esteve M, Bujanda L, Cortés X, Tosca J, Pineda JR, Mañosa M, Llaó J, Guardiola J, Pérez-Martínez I, Muñoz C, González-Lama Y, Hinojosa J, Vázquez JM, Martinez-Montiel MP, Rodríguez GE, Pajares R, García-Sepulcre MF, Hernández-Martínez A, Pérez-Calle JL, Beltrán B, Busquets D, Ramos L, Bermejo F, Barrio J, Barreiro-de Acosta M, Roncedo O, Calvet X, Hervías D, Gomollón F, Domínguez-Antonaya M, Alcaín G, Sicilia B, Dueñas C, Gutiérrez A, Lorente-Poyatos R, Domínguez M, Khorrami S, Muñoz C, Taxonera C, Rodríguez-Pérez A, Ponferrada A, Van Domselaar M, Arias-Rivera ML, Merino O, Castro E, Marrero JM, Martín-Arranz M, Botella B, Fernández-Salazar L, Monfort D, Opio V, García-Herola A, Menacho M, Ramírez-de la Piscina P, Ceballos D, Almela P, Navarro-Llavat M, Robles-Alonso V, Vega-López AB, Moraleja I, Novella MT, Castaño-Milla C, Sánchez-Torres A, Benítez JM, Rodríguez C, Castro L, Garrido E, Domènech E, García-Planella E, Gisbert JP. Casanova MJ, et al. Among authors: garrido e. Am J Gastroenterol. 2017 Jan;112(1):120-131. doi: 10.1038/ajg.2016.569. Epub 2016 Dec 13. Am J Gastroenterol. 2017. PMID: 27958281 Free article.
[Steroids in inflammatory bowel disease].
López San Román A, Garrido E. López San Román A, et al. Among authors: garrido e. Rev Esp Enferm Dig. 2015 Sep;107(9):573. Rev Esp Enferm Dig. 2015. PMID: 26334467 Free article. Spanish. No abstract available.
[Rescue therapy with sulfasalazine prior to immunosuppressive or biological agents in ulcerative colitis poorly controlled with mesalazine].
Martínez González J, Busto Bea V, Mesonero Gismero F, Parejo Carbonell S, Garrido E, López San Román A. Martínez González J, et al. Among authors: garrido e. Gastroenterol Hepatol. 2013 Jan;36(1):7-10. doi: 10.1016/j.gastrohep.2012.08.005. Epub 2012 Nov 26. Gastroenterol Hepatol. 2013. PMID: 23195755 Spanish.
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study.
Casanova MJ, Chaparro M, Nantes Ó, Benítez JM, Rojas-Feria M, Castro-Poceiro J, Huguet JM, Martín-Cardona A, Aicart-Ramos M, Tosca J, Martín-Rodríguez MDM, González-Muñoza C, Mañosa M, Leo-Carnerero E, Lamuela-Calvo LJ, Pérez-Martínez I, Bujanda L, Hinojosa J, Pajares R, Argüelles-Arias F, Pérez-Calle JL, Rodríguez-González GE, Guardiola J, Barreiro-de Acosta M, Gisbert JP; EVODIS Study Group*. Casanova MJ, et al. Aliment Pharmacol Ther. 2021 Jun;53(12):1277-1288. doi: 10.1111/apt.16361. Epub 2021 May 7. Aliment Pharmacol Ther. 2021. PMID: 33962482
346 results